SCOPUS 정보 검색 플랫폼

American Journal of Psychiatry

Volumn 161, Issue 6, 2004, Pages 1113-1115

Atypical antipsychotics and risk of cerebrovascular accidents

(3) Herrmann, Nathan a Mamdani, Muhammad b Lanctôt, Krista L b

a SUNNYBROOK RESEARCH INSTITUTE (Canada)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; LOOP DIURETIC AGENT; NEUROLEPTIC AGENT; NITRATE; OLANZAPINE; RISPERIDONE; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DRUG UTILIZATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; DEMENTIA; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RISK FACTORS; RISPERIDONE;

EID: 2942618528 PISSN: 0002953X EISSN: None Source Type: Journal
DOI: 10.1176/appi.ajp.161.6.1113 Document Type: Article

Times cited : (225)

References (8)

1
- 84880788727
- Toronto, Janssen-Ortho
- Risperdal (risperidone) and Cerebrovascular Adverse Events in Placebo-Controlled Dementia Trials: Letter to Healthcare Professionals. Toronto, Janssen-Ortho. http://www.janssen-ortho.com/JOI/en/
- Letter to Healthcare Professionals

2
- 0035500992
- Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data
- Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ: Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154:854-864
- (2001) Am J Epidemiol , vol.154 , pp. 854-864
- Schneeweiss, S.¹ Seeger, J.D.² Maclure, M.³ Wang, P.S.⁴ Avorn, J.⁵ Glynn, R.J.⁶

3
- 0023092594
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
- Charlson ME, Pompei P, Ales KL, Mackenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383
- (1987) J Chronic Dis , vol.40 , pp. 373-383
- Charlson, M.E.¹ Pompei, P.² Ales, K.L.³ Mackenzie, C.R.⁴

4
- 0021177024
- Six-month prevalence of psychiatric disorders in three communities 1980 to 1982
- Myers JK, Weissman MM, Tischler GL, Holzer CE. Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD Jr, Kramer M, et al: Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry 1984; 41:959-967
- (1984) Arch Gen Psychiatry , vol.41 , pp. 959-967
- Myers, J.K.¹ Weissman, M.M.² Tischler, G.L.³ Holzer, C.E.⁴ Leaf, P.J.⁵ Orvaschel, H.⁶ Anthony, J.C.⁷ Boyd, J.H.⁸ Burke Jr., J.D.⁹ Kramer, M.¹⁰

5
- 0032966714
- Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial
- Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M: Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 1999; 60:107-115
- (1999) J Clin Psychiatry , vol.60 , pp. 107-115
- Katz, I.R.¹ Jeste, D.V.² Mintzer, J.E.³ Clyde, C.⁴ Napolitano, J.⁵ Brecher, M.⁶

6
- 0033595555
- A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
- De Deyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S, Lawlor BA: A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999; 53:946-955
- (1999) Neurology , vol.53 , pp. 946-955
- De Deyn, P.P.¹ Rabheru, K.² Rasmussen, A.³ Bocksberger, J.P.⁴ Dautzenberg, P.L.⁵ Eriksson, S.⁶ Lawlor, B.A.⁷

7
- 0037328229
- A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia
- Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R: A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 2003; 64:134-143
- (2003) J Clin Psychiatry , vol.64 , pp. 134-143
- Brodaty, H.¹ Ames, D.² Snowdon, J.³ Woodward, M.⁴ Kirwan, J.⁵ Clarnette, R.⁶

8
- 0033799993
- Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial
- Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A (HGEU Study Group): Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2000; 57:968-976
- (2000) Arch Gen Psychiatry , vol.57 , pp. 968-976
- Street, J.S.¹ Clark, W.S.² Gannon, K.S.³ Cummings, J.L.⁴ Bymaster, F.P.⁵ Tamura, R.N.⁶ Mitan, S.J.⁷ Kadam, D.L.⁸ Sanger, T.M.⁹ Feldman, P.D.¹⁰ Tollefson, G.D.¹¹ Breier, A.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.